Cybin patent, tryptamine compounds, psychiatric neurological treatments, Mar 25
ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Summary
Cybin patent, tryptamine compounds, psychiatric neurological treatments, Mar 25
Source document (simplified)
TRYPTAMINE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
Publication EP4581013A1 Kind: A1 Mar 25, 2026
Applicants
Cybin IRL Limited
Inventors
NIVOROZHKIN, Alex, HARTSEL, Joshua A., CANAL, Clinton E., MUELLER, Tina A., AVERY, Kenneth L., VARTY, Geoffrey B., SALITURO, Francesco G., PALFREYMAN, Michael
IPC Classifications
C07D 209/16 20060101AFI20240308BHEP C07D 401/06 20060101ALI20240308BHEP A61P 25/28 20060101ALI20240308BHEP A61P 25/24 20060101ALI20240308BHEP A61K 31/4045 20060101ALI20240308BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.